AbbVie (ABBV) Operating Margin (2012 - 2026)
AbbVie's Operating Margin was 36.01% in Q3 2026, up 23.94 percentage points from 12.07% a year earlier but down 1.85 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Operating Margin (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, AbbVie's Operating Margin was 32.16% through Sep 30, 2026, up 17.01 percentage points year-over-year; for FY2025, it came in at 24.65%, up 8.43 percentage points from FY2024.
- Operating Margin shows a five-year change of -0.16 percentage points (FY2020 to FY2025).
- In earlier years, Operating Margin was 16.22% in FY2024 (-7.27 pp), 23.49% in FY2023 (-7.72 pp), 31.21% in FY2022 (-0.69 pp) and 31.89% in FY2021 (+7.09 pp).
- Quarterly Operating Margin has moved between -9.87% (Q4 2024) and 37.86% (Q2 2026) over five years.
- Compared with a year earlier, Operating Margin was higher in five of the last eight quarters, with an average year-over-year change of +3.57 percentage points.
- The best year-over-year quarter for Operating Margin over five years was Q4 2025 (a gain of 37.21 percentage points); the worst was Q4 2024 (a drop of 32.21 percentage points).
- Per Business Quant data, ABBV's Operating Margin in the three quarters before Q3 2026 was 37.86% (Q2 2026), 26.60% (Q1 2026) and 27.34% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 20.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.01% |
| Jun 30, 2026 | 37.86% |
| Mar 31, 2026 | 26.60% |
| Dec 31, 2025 | 27.34% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 31.73% |
| Mar 31, 2025 | 27.98% |
| Dec 31, 2024 | -9.87% |
| Sep 30, 2024 | 26.49% |
| Jun 30, 2024 | 27.64% |
| Mar 31, 2024 | 22.73% |
| Dec 31, 2023 | 22.34% |
| Sep 30, 2023 | 16.38% |
| Jun 30, 2023 | 32.55% |
| Mar 31, 2023 | 22.64% |
| Dec 31, 2022 | 36.39% |
| Sep 30, 2022 | 31.08% |
| Jun 30, 2022 | 22.59% |
| Mar 31, 2022 | 34.84% |
| Dec 31, 2021 | 34.09% |
API Access
AbbVie Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();